XSpray Pharma AB (XSPRAY.ST) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · Sweden · ISIN SE0009973563
XSpray Pharma AB financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 0.00 SEK | 0.00 SEK |
| Gross profit | -8.55 m SEK | -5.58 m SEK |
| Operating income | -283.24 m SEK | -161.85 m SEK |
| EBIT | -283.24 m SEK | -161.85 m SEK |
| Net income | -285.52 m SEK | -171.44 m SEK |
| Diluted EPS – continuing operations | -8.62 SEK | -4.46 SEK |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About XSpray Pharma AB
Xspray Pharma AB (publ), a pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden. The company develops Dasynoc, an amorphous version of dasatinib for the treatment of chronic myeloid leukemia (CML)and acute lymphoblastic leukemia; XS003, an amorphous non-crystalline nilotinib for the treatment of CML; XS008, an axitinib for the treatment of kidney cancer; and XS025, a amorphous non-crystalline cabozantinib for the treatment of renal cell carcinoma and other cancers. It has partnership agreements with EVERSANA for the commercialization of Dasynoc. The company was formerly known as Xspray Microparticles AB and changed its name to Xspray Pharma AB (publ) in 2017. Xspray Pharma AB (publ) was incorporated in 2003 and is headquartered in Solna, Sweden.
More stocks
- Dongil Ind (004890.KS)
- Merus Power Oyj (MERUS.HE)
- Aquawalk Group Berhad (0380.KL)
- SM Culture & Contents Co. Ltd (048550.KQ)
- Sajo Oyang (006090.KS)
- Single Well Industrial (3490.TWO)
- Sahamit Machinery Public Company Limited (SMIT.BK)
- Vbi Agro - Fundo De Investimento Imobiliario (PLAG11.SA)
- Acer Gadget Inc (2432.TW)
- TRUEN Co., Ltd. (417790.KQ)
- VOC Energy Trust (VOC)
- ADNEX GROUP BERHAD (0396.KL)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.